首页> 美国卫生研究院文献>Journal of Medical Genetics >Molecular characterisation of six patients with prolidase deficiency: identification of the first small duplication in the prolidase gene and of a mutation generating symptomatic and asymptomatic outcomes within the same family
【2h】

Molecular characterisation of six patients with prolidase deficiency: identification of the first small duplication in the prolidase gene and of a mutation generating symptomatic and asymptomatic outcomes within the same family

机译:六例蛋白水解酶缺乏症患者的分子特征:确定蛋白水解酶基因中的第一个小重复序列以及同一家族中产生有症状和无症状结果的突变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Prolidase deficiency (PD) is a rare autosomal recessive connective tissue disorder caused by mutations in the prolidase gene. The PD patients show a wide range of clinical outcomes characterised mainly by intractable skin ulcers, mental retardation and recurrent respiratory infections. Here we describe five different PEPD mutations in six European patients. We identified two new PEPD mutant alleles: a 13 bp duplication in exon 8, which is the first reported duplication in the prolidase gene and a point mutation resulting in a change in amino acid E412, a highly conserved residue among different species. The E412K substitution is responsible for the first reported phenotypic variability within a family with severe and asymptomatic outcomes.
机译:脯氨酸酶缺乏症(PD)是一种罕见的常染色体隐性遗传性结缔组织疾病,由脯氨酸酶基因的突变引起。 PD患者表现出广泛的临床结局,其主要特征是顽固性皮肤溃疡,智力低下和反复呼吸道感染。在这里,我们描述了六名欧洲患者中的五种不同的PEPD突变。我们鉴定了两个新的PEPD突变体等位基因:第8外显子13 bp重复,这是蛋白质酶基因中第一个报道的重复,以及点突变导致氨基酸E412的变化,E412是不同物种之间高度保守的残基。 E412K替代是导致严重和无症状结果的家庭中首次报告的表型变异。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号